<b>HDAC inhibitors target IRS4 to enhance </b><b>anti-androgen </b><b>receptor (AR) therapy in AR-positive triple negative breast cancer</b>
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
CAL51 cell lines were treated with Enz and Chid alone or in combination
创建时间：
2023-11-08
